305 related articles for article (PubMed ID: 19909390)
1. [Off-label-use in dermatology].
Sterry W
J Dtsch Dermatol Ges; 2009 Nov; 7(11):931-2. PubMed ID: 19909390
[No Abstract] [Full Text] [Related]
2. Off-label use in dermatology in Germany: what has changed since 2004.
Brockmeyer NH; Brucklacher U; Potthoff A; Reich-Schupke S
J Dtsch Dermatol Ges; 2009 Nov; 7(11):938-45. PubMed ID: 19386019
[TBL] [Abstract][Full Text] [Related]
3. Medical dermatology is alive and well.
Callen JP; Robinson JK
Arch Dermatol; 2005 Jul; 141(7):825-6. PubMed ID: 16027295
[No Abstract] [Full Text] [Related]
4. Off-label uses of biologic agents in dermatology: a 2006 update.
Kerns MJ; Graves JE; Smith DI; Heffernan MP
Semin Cutan Med Surg; 2006 Dec; 25(4):226-40. PubMed ID: 17174843
[TBL] [Abstract][Full Text] [Related]
5. [Off-label use].
Fritz K; Augustin M; John SM
Hautarzt; 2013 Oct; 64(10):727. PubMed ID: 24150819
[No Abstract] [Full Text] [Related]
6. Innovative uses of rituximab in dermatology.
Carr DR; Heffernan MP
Dermatol Clin; 2010 Jul; 28(3):547-57. PubMed ID: 20510764
[TBL] [Abstract][Full Text] [Related]
7. What's new in dermatologic therapy.
Thiers BH
Dermatol Ther; 2008; 21(2):142-9. PubMed ID: 18394088
[TBL] [Abstract][Full Text] [Related]
8. [Future of topical therapy].
Wohlrab J; Staubach P
Hautarzt; 2014 Mar; 65(3):168. PubMed ID: 24622850
[No Abstract] [Full Text] [Related]
9. Topical treatments in dermatology still going strong.
van de Kerkhof PC
J Dermatolog Treat; 2010 May; 21(3):125. PubMed ID: 20394487
[No Abstract] [Full Text] [Related]
10. Updates & perspectives on management of common dermatologic disorders.
Del Rosso JQ
J Drugs Dermatol; 2007 Jun; 6(6):662-4. PubMed ID: 17668533
[No Abstract] [Full Text] [Related]
11. [Dermatology].
Jung EG
Arzneimittelforschung; 1997 Oct; 47(10):1174-6. PubMed ID: 9454561
[TBL] [Abstract][Full Text] [Related]
12. Allopurinol in dermatology.
Tsai TF; Yeh TY
Am J Clin Dermatol; 2010; 11(4):225-32. PubMed ID: 20509717
[TBL] [Abstract][Full Text] [Related]
13. Key developments in dermatology.
Smith V; Sharpe G
Practitioner; 2005 Jun; 249(1671):398, 400, 402 passim. PubMed ID: 15966274
[No Abstract] [Full Text] [Related]
14. [Guidelines for therapy with fumaric acid ester].
Mrowietz U
Hautarzt; 2001 Oct; 52(10):862-4. PubMed ID: 17690813
[No Abstract] [Full Text] [Related]
15. Choosing dermatologic therapies.
Wilkin J
Dermatol Ther; 2009; 22(3):187-90. PubMed ID: 19453341
[No Abstract] [Full Text] [Related]
16. [Appropriate off-label prescription in practice].
Augustin M
Hautarzt; 2013 Oct; 64(10):728-35. PubMed ID: 24150820
[TBL] [Abstract][Full Text] [Related]
17. Repurposing of drugs for dermatologic applications: five key medications.
Adler BL; Friedman AJ
J Drugs Dermatol; 2014 Nov; 13(11):1413-6. PubMed ID: 25607712
[No Abstract] [Full Text] [Related]
18. Nanodermatology: a bright glimpse just beyond the horizon - part I.
Nasir A
Skin Therapy Lett; 2010 Sep; 15(8):1-4. PubMed ID: 20844848
[TBL] [Abstract][Full Text] [Related]
19. The use of cyclosporine in dermatology: part I.
Amor KT; Ryan C; Menter A
J Am Acad Dermatol; 2010 Dec; 63(6):925-46; quiz 947-8. PubMed ID: 21093659
[TBL] [Abstract][Full Text] [Related]
20. [Targeted therapy].
Becker JC; Hertl M
Hautarzt; 2008 Oct; 59(10):783-4. PubMed ID: 18779942
[No Abstract] [Full Text] [Related]
[Next] [New Search]
